Evidence map›Paper›PMID 41857851›Full record

ArticleBMJ open2026

Respiratory syndromic disease study in Shanghai community population.

Xiao Yu, Zexuan Wen, Wenyong Zhou, Yaxu Zheng, Jian Chen, Wen-Jia Xiao, Sheng Lin, Hongyu Liang, Xiaolei Duan, Weibing Wang and 2 more

Abstract read
In one paragraph

Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xiao Yu *Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Zexuan Wen *Department of Epidemiology, Fudan University Shanghai, Shanghai, China.
Wenyong Zhou *Department of Epidemiology, Fudan University Shanghai, Shanghai, China.
Yaxu ZhengShanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Jian ChenShanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Wen-Jia XiaoDivision of Infectious Disease Control and Prevention, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Sheng LinShanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Hongyu LiangDepartment of Epidemiology, Fudan University Shanghai, Shanghai, China.
Xiaolei DuanDepartment of Epidemiology, Fudan University Shanghai, Shanghai, China.
Weibing WangDepartment of Epidemiology, Fudan University Shanghai, Shanghai, China wwb@fudan.edu.cn chenxin_scdc@126.com wuhuanyu_scdc@126.com.ORCID http://orcid.org/0000-0002-4497-5251
Huanyu WuShanghai Municipal Center for Disease Control and Prevention, Shanghai, China wwb@fudan.edu.cn chenxin_scdc@126.com wuhuanyu_scdc@126.com.
Xin ChenShanghai Municipal Center for Disease Control and Prevention, Shanghai, China wwb@fudan.edu.cn chenxin_scdc@126.com wuhuanyu_scdc@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis prospective community-based cohort study (Acute Respiratory Infection Epidemiological Characteristics Assessment Study (ARI-ECAS)) aims to systematically monitor acute respiratory infection (ARI) incidence, characterise multiple pathogen coinfection patterns and explore microbial landscape dynamics in Shanghai's general population. By integrating syndromic surveillance, molecular diagnostics and metagenomic sequencing, the study seeks to enhance understanding of ARI epidemiology, seasonal variation and host-pathogen interactions to inform predictive modelling and optimise public health interventions in high-density urban environments.

participantsThe study enrolled 15 199 permanent residents from all 16 districts of Shanghai, with baseline oropharyngeal swab samples across five representative districts (Xuhui, Jing'an, Jiading, Songjiang and Fengxian). Inclusion criteria required residency ≥6 months and consent for weekly follow-ups. Exclusion criteria addressed mobility limitations (planned relocation >6 months) and recent ARI history. Participants provided demographic, behavioural and clinical data via the Shanghai Health Cloud platform, with baseline and symptomatic-phase biological samples collected for analysis. FINDINGS TO DATE: During the initial 8-month surveillance period (May 2024-January 2025), the ARI-ECAS cohort demonstrated critical insights into the epidemiology of acute respiratory infections in Shanghai's urban communities. Among 15 199 participants, 10.96% reported symptomatic episodes, of whom 21.43% experienced recurrent infections. Pathogen detection using targeted next-generation sequencing (tNGS) identified microbial aetiologies in 53.52% of symptomatic cases, revealing a high prevalence of coinfections: 27.96% involved dual pathogens, while 33.01% showed polymicrobial interactions (≥3 pathogens). Notably, 85.09% of symptomatic episodes were self-managed, underscoring a low healthcare-seeking rate (14.91%) consistent with patterns observed in urban China during postpandemic transitions. FUTURE PLANS: The current phase of data collection will conclude in June 2025; however, syndromic surveillance and tNGS protocols will be sustained to capture multiyear seasonal transmission patterns. To enhance comparative rigour, future protocols will aim to collect samples from participants during asymptomatic periods in the subsequent year to serve as seasonal baseline controls. Building on this foundation, the study will integrate contact behaviour and mobility surveys to quantify parameters critical for understanding pathogen transmission dynamics (eg, household contacts and public transportation usage). Furthermore, pathogen detection and metagenomic data will be combined with transcriptomic and metabolomic profiling in selected cases to model multipathogen interaction networks and delineate host immune response pathways, thereby advancing mechanistic insights into polymicrobial cocirculation.

Indexed as

Respiratory Tract InfectionsAdolescentAdultAgedChildChild, PreschoolChinaCoinfectionFemaleHumansIncidenceMaleMiddle AgedProspective StudiesSeasonsUrban PopulationEpidemiologyGenomic MedicineRespiratory infections

Identifiers

PMID41857851
PMCPMC13007062

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.